Vivtex Corp. announced the deal with Novo Nordisk worth up to $2.1 billion to develop oral drugs for conditions like obesity and diabetes.

The British pharma giant is paying cash for a Montreal-Boston biotech developing a drug for a serious lung condition.

Two biotechs take full floors at Waltham’s GENESIS 21 Hickory — about 48K sq ft added to the Route 128 lab campus.

Dash Bio launched two years ago, and until now its only facility was in downtown Boston.

Make time for The Curious Incident of the Dog in the Night-Time on the Waltham Patch calendar ...